dbio, a company specializing in health technology, has recently joined the American Heart Association Center for Health Technology & Innovation Innovators’ Network with a focus on developing innovative and scalable solutions to improve cardiovascular health and patient care globally. This partnership allows dBio to access the Association’s digital evidence-based scientific guidelines and clinical recommendations to guide the development of their digital healthcare technologies, such as the AI-powered wearable stethoscope, StethoCloud.
By collaborating with the Center, dBio aims to accelerate the adoption of transformative solutions that enhance cardiovascular care and provide real-time, actionable insights for patients and healthcare providers. StethoCloud, the world’s lightest AI wearable stethoscope, offers continuous, real-time insights into vital signs, supporting improved health outcomes and empowering better care decisions.
Through their participation in the American Heart Association’s ecosystem, dBio is aligned with the Association’s mission to advance the health of individuals and communities worldwide by driving innovation in health technology. This collaboration will help expand the reach of StethoCloud and revolutionize cardiology by capturing and analyzing heart sounds with unparalleled precision.
This partnership was highlighted at the American Heart Association’s Scientific Sessions 2024, showcasing the potential impact of StethoCloud in advancing cardiovascular care and highlighting the importance of evidence-based health tech solutions in improving patient outcomes.
Source
Photo credit finance.yahoo.com